EdwardFangMD

PubMed

• 12 citations
  Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infect...
  Alejandro Ortiz-Covarrubias, Edward Fang, Philippe Prokocimer, Shawn Flanagan, Xu Zhu, Jose Francisco Cabré-Márquez, Toshiaki Tanaka, Julie A. Passarell, Jill Fiedler-...> ;The Brazilian Journal of Infectious Diseases. 2016 Mar 1
• 118 citations
  Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections
  Andrew F. Shorr, Thomas P. Lodise, G. Ralph Corey, Carisa De Anda, Edward Fang, Anita Das, Philippe Prokocimer> ;Antimicrobial Agents and Chemotherapy. 2015 Feb 1
• 56 citations
  Platelet Profile in Patients with Acute Bacterial Skin and Skin Structure Infections Receiving Tedizolid or Linezolid: Findings from the Phase 3 ESTABLISH Clinical Trials
  Thomas P. Lodise, Edward Fang, Sonia L. Minassian, Philippe Prokocimer> ;Antimicrobial Agents and Chemotherapy. 2014 Dec 1
• 49 citations
  Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment
  Shawn Flanagan, Sonia L. Minassian, Dearbháile Morris, R. Ponnuraj, T. C. Marbury, H. W. Alcorn, Edward Fang, Philippe Prokocimer> ;Antimicrobial Agents and Chemotherapy. 2014 Nov 1
• 71 citations
  Single‐ and Multiple‐Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid
  Shawn Flanagan, Edward Fang, Kelly A. Muñoz, Sonia L. Minassian, Philippe Prokocimer> ;Pharmacotherapy. 2014 Sep 1
• 235 citations
  Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferi...
  Gregory J. Moran, Edward Fang, G. Ralph Corey, Anita Das, Carisa De Anda, Philippe Prokocimer> ;The Lancet. Infectious Diseases. 2014 Aug 1
• 26 citations
  Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: safety summary.
  Debaditya Das, Paul M Tulkens, Purvi Mehra, Edward Fang, Philippe Prokocimer> ;Clinical Infectious Diseases. 2014 Jan 1
• 79 citations
  In Vitro, In Vivo, and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions
  Shawn Flanagan, Ken Bartizal, Sonia L. Minassian, Edward Fang, Philippe Prokocimer> ;Antimicrobial Agents and Chemotherapy. 2013 Jul 1
• 112 citations
  Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration.
  Ruozhou Tom Liu, Jiangyuan Gao, Sijia Cao, Navroop Sandhu, Jing Z Cui, Chai Lin Chou, Edward Fang, Joanne A Matsubara> ;Investigative Ophthalmology & Visual Science. 2013 Mar 1
• 280 citations
  Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections: The ESTABLISH-1 Randomized Trial
  Philippe Prokocimer, Carisa De Anda, Edward Fang, Purvi Mehra, Anita Das> ;JAMA. 2013 Feb 13
• Necrotizing retinopathy after intraocular inoculation of murine cytomegalovirus in immunosuppressed adult mice.
  Holland, G. N., Fang, E. N., Glasgow, B. J., Zaragoza, A. M., Siegel, L. M., Graves, M. C., Saxton, E. H., Foos, R. Y.> ;Invest Ophthalmol Vis Sci. 1990 Nov
• Join now to see all